← back to search

Liangliang Hao

Massachusetts Institute of Technology · US
Area of research
Molecular Biology · Biomedical Engineering
Research interest
Research interests include Cancer research, Nanotechnology, Gene silencing, Pancreatic cancer, Medicine, and Cancer.
h-index
citations
969
works
13
NIH funding
primary concept
email

Recent publications

Inhalable point-of-care urinary diagnostic platform
Science Advances 2024cited by 25position: middledoi
Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system
Proceedings of the National Academy of Sciences 2024cited by 15position: firstdoi
CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics
Nature Nanotechnology 2023cited by 145position: firstdoi
CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
Journal of Visualized Experiments 2023cited by 2position: lastdoi
Microenvironment-triggered multimodal precision diagnostics
Nature Materials 2021cited by 70position: firstdoi
Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
Cancer Research 2020cited by 193position: middledoi
Acidification of Tumor at Stromal Boundaries Drives Transcriptome Alterations Associated with Aggressive Phenotypes
Cancer Research 2019cited by 249position: middledoi
Theranostic Layer‐by‐Layer Nanoparticles for Simultaneous Tumor Detection and Gene Silencing
Angewandte Chemie International Edition 2019cited by 82position: middledoi
Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
Oncotarget 2019cited by 19position: middledoi
Theranostic Layer‐by‐Layer Nanoparticles for Simultaneous Tumor Detection and Gene Silencing
Angewandte Chemie 2019cited by 19position: middledoi
iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer
Molecular Cancer Therapeutics 2018cited by 79position: middledoi
Personalized RNA Medicine for Pancreatic Cancer
Clinical Cancer Research 2018cited by 71position: middledoi
Abstract 5088: Tumor penetrating RNA delivery for therapeutic benefit of pancreatic cancer
Cancer Research 2017cited by 0position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Sangeeta N. Bhatia · Broad Institute12 papers (2017–2024)Heather E. Fleming · Massachusetts Institute of Technology5 papers (2021–2024)Renee T. Zhao · Massachusetts Institute of Technology5 papers (2020–2024)Natalie Boehnke · University of Minnesota3 papers (2019–2024)Nour Saida Harzallah · Massachusetts Institute of Technology3 papers (2023–2024)Emilia M. Pulver · The Netherlands Cancer Institute3 papers (2018–2021)Paula T. Hammond · Broad Institute3 papers (2019–2024) · 2 papers (2018–2019)Justin H. Lo · Massachusetts Institute of Technology2 papers (2017–2018)Frank B. Gertler · Massachusetts Institute of Technology2 papers (2019–2021)Nazanin Rohani · Massachusetts Institute of Technology2 papers (2019–2021)Qian Zhong · Wuhan University of Technology2 papers (2023–2024)Tyler Jacks · Howard Hughes Medical Institute2 papers (2018–2024)Henry Ko · Massachusetts Institute of Technology2 papers (2021–2023)Edward K.W. Tan · Massachusetts Institute of Technology2 papers (2023–2024)Joelle P. Straehla · Massachusetts Institute of Technology2 papers (2019–2019)Santiago Correa · Columbia University Irving Medical Center2 papers (2019–2019)Frank J. Slack · Beth Israel Deaconess Medical Center2 papers (2018–2019)Wade Wang · Massachusetts Institute of Technology2 papers (2019–2019) · 1 papers (2020–2020)